Literature DB >> 25601519

Transforming growth factor β2 (TGF-β2)-induced connective tissue growth factor (CTGF) expression requires sphingosine 1-phosphate receptor 5 (S1P5) in human mesangial cells.

Christin Wünsche1, Alexander Koch2, Roel Goldschmeding3, Stephanie Schwalm1, Dagmar Meyer Zu Heringdorf1, Andrea Huwiler4, Josef Pfeilschifter1.   

Abstract

Transforming growth factor β2 (TGF-β2) is well known to stimulate the expression of pro-fibrotic connective tissue growth factor (CTGF) in several cell types including human mesangial cells. The present study demonstrates that TGF-β2 enhances sphingosine 1-phosphate receptor 5 (S1P5) mRNA and protein expression in a time and concentration dependent manner. Pharmacological and siRNA approaches reveal that this upregulation is mediated via activation of classical TGF-β downstream effectors, Smad and mitogen-activated protein kinases. Most notably, inhibition of Gi with pertussis toxin and downregulation of S1P5 by siRNA block TGF-β2-stimulated upregulation of CTGF, demonstrating that Gi coupled S1P5 is necessary for TGF-β2-triggered expression of CTGF in human mesangial cells. Overall, these findings indicate that TGF-β2 dependent upregulation of S1P5 is required for the induction of pro-fibrotic CTGF by TGF-β. Targeting S1P5 might be an attractive novel approach to treat renal fibrotic diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Connective tissue growth factor; Human mesangial cell; Kidney; S1P receptor; Sphingosine 1-phosphate; Transforming growth factor β2

Mesh:

Substances:

Year:  2015        PMID: 25601519     DOI: 10.1016/j.bbalip.2015.01.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

2.  Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.

Authors:  Katrin G Schmidt; Martina Herrero San Juan; Sandra Trautmann; Lucija Berninger; Anja Schwiebs; Florian M Ottenlinger; Dominique Thomas; Frank Zaucke; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

Review 3.  The Emerging Role of Pathogenesis of IgA Nephropathy.

Authors:  Meng-Yu Wu; Chien-Sheng Chen; Giou-Teng Yiang; Pei-Wen Cheng; Yu-Long Chen; Hsiao-Chen Chiu; Kuan-Hung Liu; Wen-Chin Lee; Chia-Jung Li
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

4.  Sphingosine 1-Phosphate Receptor 5 (S1P5) Knockout Ameliorates Adenine-Induced Nephropathy.

Authors:  Timon Eckes; Sammy Patyna; Alexander Koch; Anke Oftring; Stefan Gauer; Nicholas Obermüller; Stephanie Schwalm; Liliana Schaefer; Jerold Chun; Hermann-Josef Gröne; Josef Pfeilschifter
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 5.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561

Review 6.  Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Authors:  Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

7.  Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells.

Authors:  J Emanuel Ramos de Carvalho; Milan T Verwoert; Ilse M C Vogels; Eric A Reits; Cornelis J F Van Noorden; Ingeborg Klaassen; Reinier O Schlingemann
Journal:  Biochem Biophys Rep       Date:  2018-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.